Clinical Outcomes of Intravesical Bacillus Calmette-Guerin (BCG) Immunotherapy in Non-Muscle-Invasive Bladder Carcinoma: A Single-Centre Prospective Analysis
International Journal of Science and Research (IJSR) · 09.04.2026 · 397-400
DOI: 10.21275/mr26404235055 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Science and Research (IJSR), erschienen am 09.04.2026. Verfasst von Kinnari Chapla und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chapla, K., & Kotadiya, S. (2026). Clinical Outcomes of Intravesical Bacillus Calmette-Guerin (BCG) Immunotherapy in Non-Muscle-Invasive Bladder Carcinoma: A Single-Centre Prospective Analysis. International Journal of Science and Research (IJSR), 397-400. https://doi.org/10.21275/mr26404235055
Vancouver
Chapla K, Kotadiya S. Clinical Outcomes of Intravesical Bacillus Calmette-Guerin (BCG) Immunotherapy in Non-Muscle-Invasive Bladder Carcinoma: A Single-Centre Prospective Analysis. International Journal of Science and Research (IJSR). 2026:397-400. doi:10.21275/mr26404235055
BibTeX
@article{Chapla2026,
author = {Chapla, Kinnari and Kotadiya, Seval},
title = {Clinical Outcomes of Intravesical Bacillus Calmette-Guerin (BCG) Immunotherapy in Non-Muscle-Invasive Bladder Carcinoma: A Single-Centre Prospective Analysis},
journal = {International Journal of Science and Research (IJSR)},
year = {2026},
pages = {397--400},
doi = {10.21275/mr26404235055}
}
EUVIMED